SEC Form 4 · accession 0001209191-17-063265
PORTOLA PHARMACEUTICALS INC · PTLA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John H Lawrence III
Officer — SVP, Chief Medical Officer
Period of report
Nov 30, 2017
Accepted (ET)
Dec 1, 2017 · 5:35 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001269021
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Nov 30, 2017 | A | 5,000 | $0.00 | A | 5,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $50.75 | Nov 30, 2017 | A | 125,000 | A | — | Nov 29, 2027 | Common Stock | 125,000 | 125,000 | D |
Explanation of responses
- F1Grant of Restricted Stock Units ("RSU") in consideration of services rendered. The RSU vests annually over three years commencing on March 1, 2019, subject to Reporting Person's Continuous Service as of each such date.
- F2The Option shall vest as follows: 25% of the shares shall vest one year from the Vesting Commencement Date of November 6, 2017, and the remaining shares shall vest ratably over the next 36 months.